Literature DB >> 14760762

Values of high-resolution computed tomography and pulmonary function tests in managements of patients with chronic hepatitis C virus infection.

Oguzhan Okutan1, Zafer Kartaloglu, Ahmet Ilvan, Ali Kutlu, Erkan Bozkanat, Emir Silit.   

Abstract

AIM: To investigate pulmonary involvement via pulmonary function tests (PFT) and high-resolution computed tomography (HRCT) in patients with chronic hepatitis C virus (HCV) infection.
METHODS: Thirty-four patients with chronic HCV infection without diagnosis of any pulmonary diseases and 10 healthy cases were enrolled in the study. PFT and HRCT were performed in all cases.
RESULTS: A decrease lower than 80% of the predicted value was detected in vital capacity in 9/34 patients, in forced expiratory volume in one second in 8/34 patients, and in forced expiratory flow 25-75 in 15/34 patients, respectively. Carbon monoxide diffusing capacity (DLCO) was decreased in 26/34 patients. Findings of interstitial pulmonary involvement were detected in the HRCT of 16/34 patients. Significant difference was found between controls and patients with HCV infection in findings of HRCT (chi2=4.7, P=0.003). Knodell histological activity index (KHAI) of 28/34 patients in whom liver biopsy was applied was 9.0+/-4.7. HRCT findings, PFT values and DLCO were not affected by KHAI in patients with HCV infection. In these patients, all the parameters were related with age.
CONCLUSION: We suggest that chronic hepatitis C virus infection may cause pulmonary interstitial involvement without evident respiratory symptoms.

Entities:  

Mesh:

Year:  2004        PMID: 14760762      PMCID: PMC4724917          DOI: 10.3748/wjg.v10.i3.381

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

1.  Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection.

Authors:  C Ferri; L La Civita; P Fazzi; S Solfanelli; F Lombardini; E Begliomini; M Monti; G Longombardo; G Pasero; A L Zignego
Journal:  Br J Rheumatol       Date:  1997-03

Review 2.  Hepatitis C: the clinical spectrum of disease.

Authors:  J H Hoofnagle
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

Review 3.  Carbon monoxide diffusing capacity.

Authors:  R O Crapo; R E Forster
Journal:  Clin Chest Med       Date:  1989-06       Impact factor: 2.878

4.  Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment.

Authors:  M Remy-Jardin; F Giraud; J Remy; L Wattinne; B Wallaert; A Duhamel
Journal:  Radiology       Date:  1994-06       Impact factor: 11.105

5.  Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis.

Authors:  R Hubbard; S Lewis; K Richards; I Johnston; J Britton
Journal:  Lancet       Date:  1996-02-03       Impact factor: 79.321

6.  Lung function, breathing pattern, and gas exchange in interstitial lung disease.

Authors:  S Javaheri; L Sicilian
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

7.  Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus.

Authors:  T Ueda; K Ohta; N Suzuki; M Yamaguchi; K Hirai; T Horiuchi; J Watanabe; T Miyamoto; K Ito
Journal:  Am Rev Respir Dis       Date:  1992-07

8.  Sarcoidosis: correlation of HRCT findings with results of pulmonary function tests and serum angiotensin-converting enzyme assay.

Authors:  Y Mimori
Journal:  Kurume Med J       Date:  1998

9.  Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia.

Authors:  C Ferri; M Monti; L La Civita; G Longombardo; F Greco; G Pasero; P Gentilini; S Bombardieri; A L Zignego
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

10.  Polymyositis, pulmonary fibrosis, and hepatitis C.

Authors:  D Weidensaul; T Imam; M M Holyst; P D King; R W McMurray
Journal:  Arthritis Rheum       Date:  1995-03
View more
  1 in total

1.  The impact of hepatitis C viremia status on lung functions in chronic hepatitis c patients.

Authors:  Tayibe Bal; Yusuf Onlen; Cenk Babayigit; Yusuf Yumer; Selma Ilkay Sahin
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.